GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a truly shift in how we approach diabetes mellitus . These new medications work by stimulating the body’s own GLP-1 hormone , which https://seolistlinks.com/story23292283/glp-1-a-major-breakthrough-in-diabetes-management